UBS and Warburg Research analysts forecast a bleak recovery ...
UBS and Warburg Research analysts forecast a bleak recovery for BASF due to low demand and high costs, likely to hit EBIT guidance's lower end. Citi analyst sees stagnating end markets further impacting earnings.
BASF's Outlook in Focus as 3Q Hit by Weak Demand -- Earnings Preview
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment